Opus Genetics (IRD) Capital Expenditures Growth (3y) (2013 - 2019)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 140.66% |
| Jun 30, 2019 | 28.62% |
| Mar 31, 2019 | 42.08% |
| Sep 30, 2018 | -3.78% |
| Jun 30, 2018 | -39.77% |
| Mar 31, 2018 | -31.77% |
| Dec 31, 2017 | 69.26% |
| Sep 30, 2017 | -39.91% |
| Jun 30, 2017 | 10.12% |
| Mar 31, 2017 | 1.69% |
| Dec 31, 2016 | -52.20% |
| Sep 30, 2016 | -74.41% |
| Jun 30, 2016 | 42.85% |
| Mar 31, 2016 | 96.15% |
| Dec 31, 2014 | -1.57% |
| Sep 30, 2014 | 91.86% |
| Jun 30, 2014 | 69.25% |
| Dec 31, 2013 | 34.93% |
| Sep 30, 2013 | 291.57% |